Article
Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels
2023-04-06
Abstract excerpt
Next generation sequencing of cell-free DNA (cfDNA) is a promising method for treatment monitoring and therapy selection in metastatic breast cancer (MBC). However, distinguishing tumor-specific variants from sequencing artefacts and germline variation with low false discovery rate is challenging when using large targeted sequencing panels covering many tumor suppressor genes. To address this, we built a machine l...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0af2dc94-a7a4-5935-bebb-72a35faad19e
- DOI
- 10.21203/rs.3.rs-2742846/v1
